| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-07 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.26 | 8e-07 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.32 | 2e-05 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.31 | 4e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.23 | 6e-05 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.19 | 8e-05 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.19 | 0.0008 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.0008 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.18 | 0.0008 |